Remove Cultivation Remove Extraction Remove Medicine Remove Supply Chain
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

This burgeoning industry encompasses a wide range of activities, including cultivation, processing, distribution, and retail sales of medical cannabis products. The establishment of cultivation, processing, and dispensary facilities creates a diverse array of employment opportunities, spanning from agricultural roles to retail positions.

article thumbnail

THC Global produces its first batch of medicinal cannabis in Australia

Cannabis Law Report

After several years of planning and navigating an exhaustive path of obtaining regulatory approvals, medicinal cannabis developer THC Global (ASX: THC) has finally completed its first round of “farm-to-pharma” cannabis processing. Serving Australian cannabis demand.

article thumbnail

Document AB-1656 Cannabis: industrial hemp. (2021-2022) Published: 01/14/2022

Cannabis Law Report

The Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities and requires the Department of Cannabis Control to administer its provisions.

Hemp 52
article thumbnail

Press Release: HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

Cannabis Law Report

Additionally, it validates the Company’s supply chain business model of providing psilocybin for clinical use and research, adding to previously announced supply partnerships this year with Mycrodose Therapeutics , Mycotopia Therapies , Cube Psytech , Allied Health , ATMA Journey Centers , Revive Therapeutics and HealthTech Connex.

article thumbnail

The Great GMP Debate–What Actually Counts as Certified Medical Cannabis Around the World

SpeedWeed

Even here, however, as in places like Australia or Canada, German inspectors must walk the floors of a cultivation plant before it is given the green light. Bottom line, when dealing with the regulating supply chain, EU-GMP is the certification that matters. Or not (see the spectacular explosion of CannTrust two summers ago).